The role of rank-ligand inhibition in the treatment of postmenopausal osteoporosis

Osteoporosis is a skeletal disease affecting millions of people worldwide in which a decreased bone mass and a microarchitectural deterioration compromise bone strength leading to bone fragility and increased susceptibility to fracture. Bone turnover increases at menopause, with osteoclast-mediated...

Full description

Bibliographic Details
Main Authors: M. Varenna, D. Gatti
Format: Article
Language:English
Published: PAGEPress Publications 2011-06-01
Series:Reumatismo
Online Access:http://www.reumatismo.org/index.php/reuma/article/view/478